Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple-assignment randomized Clinical Antipsychotic Trials of Intervention and Effectiveness schizophrenia study

Journal of the Royal Statistical Society. Series C: Applied Statistics

Volumn 61, Issue 4, 2012, Pages 577-599

  Shortreed, Susan M ^a,b   Moodie, Erica E M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Adaptive treatment strategies; Causal effects; Dynamic treatment regimes; Inverse probability weighting; Marginal structural models; Personalized medicine; Schizophrenia

Indexed keywords

EID: 84864102291     PISSN: 00359254     EISSN: 14679876     Source Type: Journal    
DOI: 10.1111/j.1467-9876.2012.01041.x     Document Type: Article

References (47)

1. Adams, C. E. (2002) Schizophrenia trials: past, present and future. Epidem. Psichiatr. Socl, 11, no. 3, 144-151.
2. Almirall, D., Ten Have, T. and Murphy, S. A. (2010) Structural nested mean models for assessing time-varying effect moderation. Biometrics, 66, 131-139.
3. Arjas, E. and Saarela, O. (2010) Optimal dynamic regimes: presenting a case for predictive inference. Int. J. Biostatist., 6, no. 2, article 10.
4. Bellman, R. (1957) Dynamic Programming. Princeton: Princeton University Press.
5. Bertsekas, D. P. and Tsitsiklis, J. N. (1996) Neuro-dynamic Programming. Belmont: Athena Scientific.
6. Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S., Fang, B., Peterson, E., Aquino, P. R., Keller, W. and S. P. O. R. T. (PORT) (2010) The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schiz. Bull., 36, 71-93.
7. van Buuren, S. (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Statist. Meth. Med. Res., 16, 219-242.
8. van Buuren, S., Brand, J. P. L., Groothuis-Oudshoorn, C. G. M. and Rubin, D. B. (2006) Fully conditional specification in multivariate imputation. J. Statist. Computn Simuln, 76, 1049-1064.
9. Cain, L. E., Robins, J. M., Lanoy, E., Logan, R., Costagliola, D. and Hernán, M. A. (2010) When to start treatment?: a systematic approach to the comparison of dynamic regimes using observational data. Int. J. Biostatist., 6, no. 2, article 18.
10. Chakraborty, B., Murphy, S. A. and Strecher, V. (2010) Inference for non-regular parameters in optimal dynamic treatment regimes. Statist. Meth. Med. Res., 19, 317-343.
11. Cotton, C. A. and Heagerty, P. J. (2011) A data augmentation method for estimating the causal effect of adherence to treatment regimens targeting control of an intermediate measure. Statist. Biosci., 3, 28-44.
12. Heinrichs, D. W., Hanlon, T. E. and Carpenter, W. T. (1984) Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schiz. Bull., 10, 388-398.
13. Henderson, R., Ansell, P. and Alshibani, D. (2010) Regret-regression for optimal dynamic treatment regimes. Biometrics, 6, 1192-1201.
14. Hernán, M. A., Brumback, B. and Robins, J. M. (2000) Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology, 11, 561-570.
15. Hernán, M. A., Lanoy, E., Costagliola, D. and Robins, J. M. (2006) Comparison of dynamic treatment regimes via inverse probability weighting. Basic Clin. Pharmcol. Toxcol., 98, 237-242.
16. Jose, M., Alvir, J., Lieberman, J. A., Safferman, A. Z., Schwimmer, J. L. and Schaaf, J. A. (1993) Clozapine-induced agranulocytosis-incidence and risk factors in the United States. New Engl. J. Med., 329, 162-167.
17. Kay, S. R., Flazbein, A. and Opler, L. A. (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schiz. Bull., 13, 261-276.
18. van der Laan, M. J. and Petersen, M. L. (2007) Causal effect models for realistic individualized treatment and intention to treat rules. Int. J. Biostatist., 3, no. 1, article 3.
19. van der Laan, M. J. and Robins, J. M. (2003) Unified Methods for Censored Longitudinal Data and Causality. New York: Springer.
20. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S., Davis, C. E., Lebowitz, B. D. and Severe, J. (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl. J. Med., 353, 1209-1223.
21. Lunceford, J. K., Davidian, M. and Tsiatis, A. A. (2002) Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics, 58, 48-57.
22. Margolese, H., Chouinard, G., Kolivakis, T., Beauclair, L., Miller, R. and Annable, L. (2005) Tardive dyskinesia in the era of typical and atypical antipsychotics, part 2: Incidence and management strategies in patients with schizophrenia. Can. J. Psychiatr., 50, 703-714.
23. McEvoy, J. P., Lieberman, J. A., Stroup, T. S., Davis, S., Meltzer, H. Y., Rosenheck, R. A., Swartz, M. S., Perkins, D. O., Keefe, R. S. E., Davis, C. E., Severe, J. and Hsiao, J. K. (2006) Effectiveness of clozapine versus olanzapine, quetiapine and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am. J. Psychiatr., 163, 600-610.
24. Moodie, E., Richardson, T. and Stephens, D. (2007) Demystifying optimal dynamic treatment regimes. Biometrics, 63, 447-455.
25. Murphy, S. A. (2003) Optimal dynamic treatment regimes (with discussion). J. R. Statist. Soc. B, 65, 331-366.
26. Murphy, S. A. (2005) A generalization error for Q-learning. J. Mach. Learn. Res., 6, 1073-1097.
27. Nevalainen, J., Kenward, M. G. and Virtanen, S. M. (2009) Missing values in longitudinal dietary data: a multiple imputation approach based on a fully conditional specification. Statist. Med., 28, 3657-3669.
28. Neyman, J. (1990) On the application of probability theory to agricultural experiments: essay in principles, section 9. Statist. Sci., 5, 472-480.
29. Orellana, L., Rotnitzky, A. and Robins, J. M. (2010a) Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, part I: Main content. Int. J. Biostatist., 6, no. 2, article 8.
30. Orellana, L., Rotnitzky, A. and Robins, J. M. (2010b) Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, part II: Proofs and additional results. Int. J. Biostatist., 6, no. 2, article 9.
31. Pineau, J., Bellemare, M. G., Rush, A. J., Ghizaru, A. and Murphy, S. A. (2007) Constructing evidence-based treatment strategies using methods from computer science. Drug Alc. Depend., 88, S52-S60.
32. Robins, J. M. (1986) A new approach to causal inference in mortality studies with sustained exposure periods-application to control of the healthy worker survivor effect. Math. Modllng, 7, 1393-1512.
33. Robins, J. M. (1999) Association, causation, and marginal structural models. Synthese, 121, 151-179.
34. Robins, J. M. (2004) Optimal structural nested models for optimal sequential decisions. In Proc. 2nd Seattle Symp. Biostatistics, New York (eds D. Y. Lin and P. Heagerty ), pp. 189-326. New York: Springer.
35. Robins, J. M., Hernán, M. A. and Brumback, B. (2000) Marginal structural models and causal inference in epidemiology. Epidemiology, 11, 550-560.
36. Robins, J. M., Orellana, L. and Rotnitzky, A. (2008) Estimation and extrapolation of optimal treatment and testing strategies. Statist. Med., 27, 4678-4721.
37. Rubin, D. B. (1978) Bayesian inference for causal effects: the role of randomization. Ann. Statist., 6, 34-58.
38. Sachdev, P. (2000) The current status of tardive dyskinesia. Aust. New Zeal. J. Psychiatr., 34, 355-369.
39. Schafer, J. L. (1997) Imputation of missing covariates under a multivariate linear mixed model. Technical Report. Department of Statistics, Pennsylvania State University, University Park.
40. Schafer, J. L. and Yucel, R. M. (2002) Computational strategies for multivariate linear mixed models with missing values. J. Computnl Graph. Statist., 11, 421-442.
41. Shao, J. and Sitter, R. R. (1996) Bootstrap for imputed survey data. J. Am. Statist. Ass., 91, 1278-1288.
42. Shortreed, S. M., Laber, E. and Murphy, S. A. (2010) Imputations methods for the clinical antipsychotic trials of intervention and effectiveness study. Technical Report SOCS-TR-2010.8. School of Computer Science, McGill University, Montreal.
43. Stroup, T. S., Lieberman, J. A., McEvoy, J. P., Davis, S. M., Meltzer, H. Y., Rosenheck, R. A., Swartz, M. S., Perkins, D. O., Keefe, R. S. E., Davis, C. E., Severe, J. and Hsiao, J. K. (2006) Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Am. J. Psychiatr., 163, 611-622.
44. Stroup, T. S., McEvoy, J. P., Swartz, M. S., Byerly, M. J., Glick, I. D., Canive, J. M., McGee, M., Simpson, G. M., Stevens, M. D. and Lieberman, J. A. (2003) The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schiz. Bull., 29, 15-31.
45. Swartz, M. S., Perkins, D. O., Stroup, T. S., McEvoy, J. P., Nieri, J. M. and Haal, D. D. (2003) Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schiz. Bull., 29, 33-43.
46. Thall, P. F., Sung, H. G. and Estey, E. H. (2009) Selecting therapeutic strategies based on ecacy and death in multicourse clinical trials. J. Am. Statist. Ass., 97, 29-39.
47. Wahed, A. S. and Tsiatis, A. A. (2004) Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics, 60, 124-133.